Gynecologic Cancer Prevention and Control

A move from treatment to counteractive action of the three noteworthy gynecologic diseases:  Cervical tumor remains the fourth most regular disease, influencing ladies worldwide with vast geographic varieties in cervical malignancy frequency and death rates.. Similarly as with other such infections, obstruction and spermicidal contraceptives bring down the danger of cervical tumor; the hazards decrease approximate 50%. Combinational contraceptives help anticipate both endometrial and epithelial ovarian tumors. The danger of endometrial tumor among previous oral preventative clients is decreased by around 50% and that of ovarian malignancy by around 30% to 80%. Weight control presents solid assurance against endometrial growth. Breast feeding and tubal sterilization seems to ensure against ovarian growth. In spite of the fact that ladies have a scope, of practical, effective measures accessible to diminish their danger of these malignancies, and few know about them. A few confirmation based mediations are accessible to lessen the occurrence, dreariness, and mortality from these growths. The National Comprehensive Cancer Control Program (NCCCP) is remarkably situated to actualize these interventions in the US population.

  • Prevention of cervical cancer
  • Prevention of vulvar cancer
  • Prevention and early detection of vaginal cancer
  • Prevention of epithelial ovarian cancer
  • Risk assessment

Related Conference of Gynecologic Cancer Prevention and Control

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Gynecologic Cancer Prevention and Control Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in